Tag Archives: Six Sigma

DIA: Does Six Sigma Stifle R&D Innovation?

Can the management style known as Six Sigma help improve the probability of a drug’s commercial success, or do its black-belted acolytes punch holes in the creative process needed for innovative R&D discovery?
Posted in IP, leadership, R&D, Strategy | Also tagged , , | 4 Comments
  • Categories

  • Meta